major insurance changes are coming to glp 1 Your Employer Can Cover Your GLP-1 — No Required GLP-1 Insurance - Why Employers

Research suggests tirzepatide may be more effective than semaglutide for weight loss

Regarding GLP-1 products specifically, both novel and increased levels of impurities have been identified by Novo Nordisk in compounded versus originator semaglutide samples, posing some risk of immunogenicity (Hach et al., 2024)

We provide high-quality compounded medications from US-based pharmacies

Seccombe DW, James L, Booth F

"So that's where I feel we need to be more realistic in terms of potential cost savings." The medications would also, likely, need to be on the PBS to be accessible, as a high proportion of people who fall into the overweight and obese categories experience socio-economic disadvantage

The pharmacokinetics of empagliflozin has been characterized in healthy volunteers and patients with type 2 diabetes mellitus and no clinically relevant differences were noted between the two populations